Search results
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
CNBC· 5 days agoModerna on Thursday posted a narrower-than-expected loss for the first quarter as the company's...
What to know about the new 'FLiRT' COVID variants that are spreading: Your guide to the latest virus...
Yahoo Life· 12 hours agoHere’s your go-to guide with everything you need to know about COVID-19, including the latest...
Moderna Stock Takes Minimal Hit After New COVID Vaccine Topped Projected Estimates
Black Enterprise· 4 days agoModerna announced an increase in stock price after their COVID vaccine exceeded sales estimates for...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 4 days agoModerna’s next focus is to continue rolling out mRNA vaccines, which teaches cells how to make the...
Unveiling Moderna (MRNA)'s Value: Is It Really Priced Right? A C
Guru Focus· 12 hours agoPer Share standing at 15.67, this analysis seeks to delve deep into Moderna's valuation, encouraging investors to scrutinize the following insights. Moderna
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025...
Benzinga via Yahoo Finance· 4 days agoThursday, Moderna Inc (NASDAQ:MRNA) reported a first-quarter EPS loss of $(3.07), down from an...
Moderna posts better-than-expected quarterly results as it looks to fall RSV vaccine launch
Market Watch· 5 days agoA Food and Drug Administration decision on approval of Moderna’s RSV vaccine is expected by May 12,...
Moderna Puts Up Big Quarterly Beat; Could Shares Break Out?
Investor's Business Daily· 5 days agoModerna (MRNA) beat Wall Street's first-quarter expectations Thursday. The Covid vaccine maker came...
Moderna Inc (MRNA)'s Uncertain Future: Understanding the Barrier
Guru Focus· 11 hours agoLong-established in the Biotechnology industry, Moderna Inc (MRNA, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth ...
Moderna, Inc. (NASDAQ:MRNA) Expected to Earn Q3 2025 Earnings of $1.30 Per Share
ETF DAILY NEWS· 24 hours agoModerna, Inc. (NASDAQ:MRNA – Free Report) – Equities research analysts at William Blair lifted their Q3 2025 EPS estimates for Moderna in a report released ...